U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Transcription profiling of MamBo cell lines

(Submitter supplied) We studied cell lines derived from two transgenic mammary tumors driven by human HER2 that showed different dynamics of HER2 status. MamBo89 (HER2 stable) cell line displayed high and stable HER2 expression, which was maintained upon in vivo passages, whereas MamBo43 (HER2 labile) cell line gave rise to HER2-negative tumors, from which MamBo38 (HER2 loss) cell line was derived. MamBo cell lines were established from mammary tumors of FVBhuHER2 virgin female mice.
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL19057
11 Samples
Download data: TXT
Series
Accession:
GSE181468
ID:
200181468
2.

Mutant PI3K cooperates with HER2 to promote mammary tumor formation and induces trastuzumab resistance in vivo

(Submitter supplied) HER2 (ERBB2) gene amplification and PIK3CA mutations often co-occur in breast cancer, and aberrant activation of the PI3K pathway has been implicated in resistance to HER2-directed therapies. We have created a mouse model of HER2-overexpressing (HER2+), PIK3CAH1047R-mutant breast cancer. Mice expressing both human HER2 and mutant PIK3CA in their mammary glands developed tumors with a significantly shorter latency compared to mice expressing either oncogene alone. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL11383
19 Samples
Download data
Series
Accession:
GSE41118
ID:
200041118
3.

Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Non-coding RNA profiling by array; Expression profiling by array; Genome variation profiling by genome tiling array
Platforms:
GPL2884 GPL4134 GPL16199
96 Samples
Download data: TXT
Series
Accession:
GSE41748
ID:
200041748
4.

Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer (miRNA expression data).

(Submitter supplied) miRNA profiling of normal and tumorigenic mouse mammary tissue. Mouse genotypes consist of wildtype, MMTV-Met, MMTV-Met;Trp53fl/+;Cre, and Trp53fl/+;Cre.
Organism:
Mus musculus
Type:
Non-coding RNA profiling by array
Platform:
GPL16199
25 Samples
Download data: TXT
Series
Accession:
GSE41723
ID:
200041723
5.

Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer (aCGH data).

(Submitter supplied) Transcriptional profiling of normal and tumorigenic mouse mammary tissue. Mouse genotypes consist of wildtype, MMTV-Met, MMTV-Met;Trp53fl/+;Cre, and Trp53fl/+;Cre.
Organism:
Mus musculus
Type:
Genome variation profiling by genome tiling array
Platform:
GPL2884
30 Samples
Download data: TXT
Series
Accession:
GSE41632
ID:
200041632
6.

Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer (mRNA expression data).

(Submitter supplied) Transcriptional profiling of normal and tumorigenic mouse mammary tissue. Mouse genotypes consist of wildtype, MMTV-Met, MMTV-Met;Trp53fl/+;Cre, and Trp53fl/+;Cre.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL4134
41 Samples
Download data: TXT
Series
Accession:
GSE41601
ID:
200041601
7.

Mammary Tissue: Wild type mammary glands vs IGF-IR induced mammary tumors vs IGF-IR independent tumors

(Submitter supplied) Molecular profiling was used to classify mammary tumors that develop in MTB-IGFIR transgenic mice. It was determined that the primary mammary tumors (PMT), which develop due to elevated expression of the type I insulin-like growth factor receptor (IGF-IR) in mammary epithelial cells, most closely resemble murine tumors with basal-like or mixed gene expression profiles and with human basal-like breast cancers. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL7202
28 Samples
Download data: TXT
Series
Accession:
GSE32152
ID:
200032152
8.

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer

(Submitter supplied) WAP-Cre:Ptenf/f:p53lox.stop.lox_R270H composite mice were generated by genetic crossing. In these mice, Pten is deleted and a R270H p53 mutation in the DNA binding domain is induced upon expression of Cre recombinase in pregnancy-identified alveolar progenitors. Tumors were characterized by histology, marker analysis, various bioinformatics methods, high-throughput (HTP) FDA-drug screen as well as orthotopic injection to quantify tumor initiating cells (TICs) and tail-vein injection to identify lung-metastasis. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6246
31 Samples
Download data: CEL
Series
Accession:
GSE75989
ID:
200075989
9.

Gene expression profiling of transgenic d16HER2- and WT HER2-positive transgenic mammary tumor cell lines

(Submitter supplied) d16HER2 is a splice variant of HER2 receptor characterized by a significant tumor aggressiveness. We derived primary tumor cell lines from spontaneous tumors grown in mice transgenic respectively for human d16 (MI6 and MI7 cell lines) and WT HER2 isoforms (WTHER2_1 and WTHER2_2). To analyze the molecular mechanisms underlying the higher tumorigenicity of d16HER2 than that of WTHER2, we conducted gene expression profiling analysis of these cell lines.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6887
16 Samples
Download data: TXT
Series
Accession:
GSE67300
ID:
200067300
10.

HMLER cells expressing either FOXC2 or a vector control

(Submitter supplied) We used microarrays to investigate the transcription profile of FOXC2 expression in a human mammary epithelial cell line.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
6 Samples
Download data: CEL
Series
Accession:
GSE44335
ID:
200044335
11.

HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib

(Submitter supplied) HER2 targeting with trastuzumab has changed the prognosis of breast cancer patients carrying amplification and/or overexpression of this oncogene. Despite this progress, however, resistance to trastuzumab occurs in the vast majority of patients. Newer anti-HER2 therapies, like the dual tyrosine-kinase inhibitor (TKI) lapatinib, show antitumor activity in a limited proportion of patients, indicating that HER2 can be still exploited as a target after trastuzumab failure. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
2 Samples
Download data: TXT
Series
Accession:
GSE17630
ID:
200017630
12.

Gene expression of primary MMTV-Neu tumors compared to secondary tumors generated from lin- and single tumor initiating cell (TIC) transplantation

(Submitter supplied) Most solid tumors seem to be organized in a hierarchy in which only a fraction of cells, termed tumor-initiating cells (TICs), is capable of disseminating new tumors after transplantation into recipient mice. However, whether a single TIC can induce a tumor or whether it requires additional TICs or non-TICs for tumor initiation is not known. Here we show that injections of single CD24+:Jag1- cells from Her2/Neu+ mammary tumors into recipient mammary glands induced tumors at a frequency of 1/22. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS4099
Platform:
GPL6885
16 Samples
Download data: TXT
Series
Accession:
GSE29616
ID:
200029616
13.

Expression data from highly purified MMTV-Neu Tumor Initiating Cells (TICs) and the non-TIC CD24- fraction

(Submitter supplied) The cancer stem cell model maintains that tumors are organized in a hierarchy driven by tumor initiating cells (TICs), and that patient survival inversely correlates with TIC gene expression. Here we generated a prognostic signature for HER2+ breast cancer from TICs purified from MMTV-Her2/Neu mammary tumors. TICs from this model, identified as Lin-:CD24+:JAG1- at a frequency of 2-5% by serial and single cell transplantation assays, showed elevated expression of proliferation genes and low expression of differentiation genes (compared to non-TIC fraction CD24- of the same tumor). more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6246
8 Samples
Download data: CEL
Series
Accession:
GSE29590
ID:
200029590
14.
Full record GDS4099

Human Epidermal Growth Factor Receptor 2-positive breast cancer MMTV-Her2/Neu murine model: primary and secondary mammary tumors

Analysis of primary MMTV-Neu mammary tumors and secondary tumors generated by lin- cell transplantation or by single tumor-initiating cell (TIC) transplantation. Results enable molecular comparisons between the primary and secondary tumors.
Organism:
Mus musculus
Type:
Expression profiling by array, count, 16 specimen, 3 tissue sets
Platform:
GPL6885
Series:
GSE29616
16 Samples
Download data
15.

Controlled ErbB receptor dimerization

(Submitter supplied) In order to better understand signaling events following receptor dimerization involving HER2, we have generated an experimental system in which ErbB dimerization can be controlled. We used gene expression microarrays to identify genes and pathways that are differentially activated by HER2 homodimers and HER2 containing heterodimers.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4361
Platform:
GPL6244
12 Samples
Download data: CEL, CHP
Series
Accession:
GSE22288
ID:
200022288
16.
Full record GDS4361

AP1510, TGFα or heregulin ligand effect on MCF10 mammary epithelial cells expressing HER2-FKBP-HA chimeric receptors

Analysis of mammary epithelial MCF10A/HER2/FKBP/HA cells treated with AP1510 to induce the chimeric HER2-FKBP molecule to homodimerize, or with TGFα or heregulin to induce heterodimerization with EGFR or HER3. Results provide insight into signaling events following HER2 receptor dimerization.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 4 agent sets
Platform:
GPL6244
Series:
GSE22288
12 Samples
Download data: CEL, CHP
17.

Multipotent mammary cancer stem cells integrate stem cell and clonal expansion theories of tumor progression

(Submitter supplied) The diversity of human breast cancer subtypes has led to the hypothesis that breast cancer is a number of different diseases arising from cells at various stages of differentiation. We have derived clonal multipotent metastatic mammary cancer stem cells from the polyomavirus middle T mouse model of breast cancer, that can differentiate into luminal, myoepithelial and alveolar cells. When injected orthotopically at low-density, the resulting tumors express estrogen and progesterone receptors. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL15887
43 Samples
Download data: PAIR
Series
Accession:
GSE61138
ID:
200061138
18.

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

(Submitter supplied) A survey of the somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; SNP genotyping by SNP array
Platforms:
GPL13314 GPL8882
26 Samples
Download data: TXT
Series
Accession:
GSE31645
ID:
200031645
19.

MCF10A cells expressing HER2 and HER3 and grown in three-dimensional cultures

(Submitter supplied) The tyrosine kinase receptors HER2 and HER3 play an important role in breast cancer. The HER2/HER3 heterodimer is a critical oncogenic unit associated with reduced relapse-free and decreased overall survival. We provide gene expression profile of the mammary epithelial cells MCF10A expressing HER2, HER3 or HER2/HER3 and grown in three-dimensional cultures for 15 days in the presence of heregulin, a known HER3-ligand that stabilizes and activates the HER2/HER3 heterodimer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4359
Platform:
GPL6244
8 Samples
Download data: CEL
Series
Accession:
GSE37009
ID:
200037009
20.
Full record GDS4359

Co-expression of tyrosine kinase receptors HER2 and HER3 in mammary epithelial cells MCF10A grown in three-dimensional cultures

Analysis of MCF10A mammary epithelial cells expressing HER2, HER3, or HER2/HER3 heterodimer. Co-expression of HER2 and HER3 induced migration and invasion of MCF10A cells. Results provide insight into the role of HER2 and HER3 in breast cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 4 genotype/variation sets
Platform:
GPL6244
Series:
GSE37009
8 Samples
Download data: CEL
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_674c48dad826084038506017|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center